FR3036284B1 - LIPOIC ACID AS OSMOPROTECTIVE AGENT - Google Patents

LIPOIC ACID AS OSMOPROTECTIVE AGENT Download PDF

Info

Publication number
FR3036284B1
FR3036284B1 FR1554590A FR1554590A FR3036284B1 FR 3036284 B1 FR3036284 B1 FR 3036284B1 FR 1554590 A FR1554590 A FR 1554590A FR 1554590 A FR1554590 A FR 1554590A FR 3036284 B1 FR3036284 B1 FR 3036284B1
Authority
FR
France
Prior art keywords
lipoic acid
osmoprotective agent
osmoprotective
agent
lipoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1554590A
Other languages
French (fr)
Other versions
FR3036284A1 (en
Inventor
Martine Claret
Claude Claret
Caroline CHATARD-BAPTISTE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ophtalmis Monaco
Original Assignee
Ophtalmis Monaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1554590A priority Critical patent/FR3036284B1/en
Application filed by Ophtalmis Monaco filed Critical Ophtalmis Monaco
Priority to US15/575,187 priority patent/US11224588B2/en
Priority to BR112017024804-2A priority patent/BR112017024804B1/en
Priority to EP16726819.2A priority patent/EP3297733A1/en
Priority to US15/575,200 priority patent/US10940206B2/en
Priority to EP16727328.3A priority patent/EP3297626B1/en
Priority to RU2017142726A priority patent/RU2724955C2/en
Priority to CN201680028833.6A priority patent/CN107820422B/en
Priority to RU2017142379A priority patent/RU2726978C2/en
Priority to PCT/EP2016/061362 priority patent/WO2016185000A1/en
Priority to JP2017560794A priority patent/JP6785796B2/en
Priority to JP2017560808A priority patent/JP6785797B2/en
Priority to CN201680028789.9A priority patent/CN107864623A/en
Priority to ES16727328T priority patent/ES2883956T3/en
Priority to BR112017024805-0A priority patent/BR112017024805B1/en
Priority to CA2985013A priority patent/CA2985013C/en
Priority to CA2985014A priority patent/CA2985014C/en
Priority to PCT/EP2016/061358 priority patent/WO2016184998A1/en
Priority to PL16727328T priority patent/PL3297626T3/en
Publication of FR3036284A1 publication Critical patent/FR3036284A1/en
Publication of FR3036284B1 publication Critical patent/FR3036284B1/en
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
FR1554590A 2015-05-21 2015-05-21 LIPOIC ACID AS OSMOPROTECTIVE AGENT Active FR3036284B1 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR1554590A FR3036284B1 (en) 2015-05-21 2015-05-21 LIPOIC ACID AS OSMOPROTECTIVE AGENT
PCT/EP2016/061358 WO2016184998A1 (en) 2015-05-21 2016-05-20 Combination of lipoic acid and taurine as osmoprotective agent
JP2017560808A JP6785797B2 (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and a mucosal mimicking polymer
US15/575,200 US10940206B2 (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and a mucomimetic polymer
EP16727328.3A EP3297626B1 (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and hyaluronic acid
RU2017142726A RU2724955C2 (en) 2015-05-21 2016-05-20 Ophthalmic composition containing lipoic acid and a mucomimetic polymer
CN201680028833.6A CN107820422B (en) 2015-05-21 2016-05-20 Ophthalmic compositions comprising lipoic acid and mucoid polymers
RU2017142379A RU2726978C2 (en) 2015-05-21 2016-05-20 Combination of lipoic acid and taurine as osmoprotective agent
PCT/EP2016/061362 WO2016185000A1 (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and a mucomimetic polymer
ES16727328T ES2883956T3 (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and hyaluronic acid
US15/575,187 US11224588B2 (en) 2015-05-21 2016-05-20 Combination of lipoic acid and taurine as osmoprotective agent
EP16726819.2A EP3297733A1 (en) 2015-05-21 2016-05-20 Combination of lipoic acid and taurine as osmoprotective agent
JP2017560794A JP6785796B2 (en) 2015-05-21 2016-05-20 Combination of lipoic acid and taurine as osmoprotectant
BR112017024805-0A BR112017024805B1 (en) 2015-05-21 2016-05-20 COMBINATION OF LIPOIC ACID AND TAURINE AS OSMOPROTECTIVE AGENT
CA2985013A CA2985013C (en) 2015-05-21 2016-05-20 Combination of lipoic acid and taurine as osmoprotective agent
CA2985014A CA2985014C (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and a mucomimetic polymer
BR112017024804-2A BR112017024804B1 (en) 2015-05-21 2016-05-20 OPHTHALMIC COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION, PROCESS FOR PREPARING THE OIL-IN-WATER EMULSION, AND USE OF LIPOIC ACID
PL16727328T PL3297626T3 (en) 2015-05-21 2016-05-20 Ophthalmic composition comprising lipoic acid and hyaluronic acid
CN201680028789.9A CN107864623A (en) 2015-05-21 2016-05-20 Combination as the lipoic acid and taurine of osmoprotectant

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1554590A FR3036284B1 (en) 2015-05-21 2015-05-21 LIPOIC ACID AS OSMOPROTECTIVE AGENT
FR1554590 2015-05-21

Publications (2)

Publication Number Publication Date
FR3036284A1 FR3036284A1 (en) 2016-11-25
FR3036284B1 true FR3036284B1 (en) 2018-10-12

Family

ID=53524878

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1554590A Active FR3036284B1 (en) 2015-05-21 2015-05-21 LIPOIC ACID AS OSMOPROTECTIVE AGENT

Country Status (1)

Country Link
FR (1) FR3036284B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113797162B (en) * 2020-06-17 2023-05-05 成都瑞沐生物医药科技有限公司 An ophthalmic preparation for treating macular edema, optic neuritis and non-infectious endophthalmitis by eye drop administration

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817630A (en) * 1997-03-18 1998-10-06 Austin Nutriceutical Corporation Glutathione antioxidant eye drops
PT1294353E (en) * 2000-06-06 2006-07-31 Basf Ag USE OF LIPOIC ACID ENANTIOMER (R) IN COSMETIC AND DERMATOLOGICAL COMPOSITIONS
FR2832637B1 (en) * 2001-06-07 2004-07-30 Lefaix Marie Therese Droy USE OF AN ANTIOXIDANT FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF EYE SURFACE CONDITIONS
DE10229995A1 (en) * 2002-07-03 2004-01-15 Beiersdorf Ag Cosmetic or dermatological compositions containing alpha-lipoic acid are stabilized against breakdown by adjusting the pH to 7.1-8.5
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
US20050192229A1 (en) * 2004-02-27 2005-09-01 Perricone Nicholas V. Topical glutathione treatments
US20060188492A1 (en) * 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
BRPI0800818A2 (en) * 2008-02-13 2009-09-29 Eziquiel Henrique Cinacchi topical composition of eye drops for prevention and treatment of cataract and nuclear sclerosis in domestic animals
JP2013241398A (en) * 2012-04-27 2013-12-05 Fujifilm Corp β-GLUCOCEREBROSIDASE ACTIVITY ENHANCER, CERAMIDE PRODUCTION ENHANCER, AND SKIN BARRIER FUNCTION IMPROVING AGENT
CN103860625A (en) * 2013-02-20 2014-06-18 成都尖卡斌科技有限公司 Cranberry extract eye ophthalmic preparation and preparation method and uses thereof

Also Published As

Publication number Publication date
FR3036284A1 (en) 2016-11-25

Similar Documents

Publication Publication Date Title
MA48994A (en) ISOQUINOLEINS USED AS HPK1 INHIBITORS
MA42990A (en) COMPOUNDS USEFUL AS IMMUNOMODULATORS
MA47123A (en) BENZOOXAZOLE DERIVATIVES AS MMUNOMODULATORS
MA47125A (en) PYRAZOLE DERIVATIVES AS MALT1 INHIBITORS
MA42615A (en) BETA-AMINO ACID ANTIVIRAL PHOSPHODIAMIDE COMPOUNDS
MA55194A (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
MA40587A (en) AMINOPYRIMIDINYL COMPOUNDS AS JAK INHIBITORS
MA40943A (en) SUBSTITUTED PYRROLOPYRIDINES USED AS BROMODOMA INHIBITORS
MA40940A (en) SUBSTITUTED PYRROLOPYRIDINES USED AS BROMODOMA INHIBITORS
MA46981A (en) BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS
MA40775A (en) 4- (4- (4-PHENYLUREIDO-NAPHTALÉN -1-YL) OXY-PYRIDIN-2-YL) AMINO-BENZOIC ACID USED AS A KINASE P38 INHIBITOR
MA43169A (en) HETEROCYCLIC COMPOUNDS USED AS PI3K-GAMMA INHIBITORS
MA42032A (en) 3-ARYL-4-AMIDO-BICYCLO [4,5,0] HYDROXAMIC ACIDS AS HDAC INHIBITORS
MA42659A (en) HETERARYL DERIVATIVES USED AS PARP INHIBITORS
MA47179A (en) COMPOSITION OF MANNURONIC DICARBOXYLIC ACID
MA46180A (en) ANALOGUES OF AMYLINE
MA46878A (en) BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS
MA44868A (en) 3-METHYLCROTONIC ACID (MDC) DECARBOXYLASE VARIANTS
FR3015290B1 (en) HYALURONIC ACID COMPOSITIONS COMPRISING MEPIVACAINE
MA41542A (en) NEW N-ACYL-ARYLSULFONAMIDE DERIVATIVES USED AS AMINOACYL-ARNT SYNTHETASE INHIBITORS
DK3544584T3 (en) PHARMACEUTICAL PARENTERAL FORMULATION CONTAINING CARGLUMIC ACID
DK3474858T3 (en) TWO-COMPONENT COMPOSITION INCLUDING ACETYL SALICYLIC ACID
MA41174A (en) IMIDAZOPYRIDAZINE DERIVATIVES USED AS PI3KBETA INHIBITORS
DK3402573T3 (en) AMINO ACID COMPOSITION
DK3369429T3 (en) PHARMACEUTICAL COMPOSITION INTENDED TO BE ADMINISTRATED TO THE NOSE

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20161125

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9